Inventor · disambiguated record
Yu Mi Ahn
Also filed as: AHN YU MI
8 granted patents·8 pending applications·55 citations·filing 2020–2024
82Inventor score
Files withDECIPHERA PHARMACEUTICALS LLC16
Top patents by PatentIndex Score
16 records- 0197US11590134B2Aminopyrimidine amide autophagy inhibitors and methods of use thereofDECIPHERA PHARMACEUTICALS LLC·Filed 2020·Granted Feb 28, 2023·19 cites·20 claims
- 0297US11530206B2Phenylaminopyrimidine amide autophagy inhibitors and methods of use thereofDECIPHERA PHARMACEUTICALS LLC·Filed 2020·Granted Dec 20, 2022·20 cites·37 claims
- 0397US11518758B2Heteroarylaminopyrimidine amide autophagy inhibitors and methods of use thereofDECIPHERA PHARMACEUTICALS LLC·Filed 2020·Granted Dec 6, 2022·16 cites·20 claims
- 0480US2025084073A1Phenylaminopyrimidine amide autophagy inhibitors and methods of use thereofDECIPHERA PHARMACEUTICALS LLC·Filed 2024·Application pending·0 cites
- 0576US2025250235A1Raf kinase inhibitors and methods of use thereofDECIPHERA PHARMACEUTICALS LLC·Filed 2024·Application pending·0 cites
- 0674US12377097B2Aminopyrimidine amide autophagy inhibitors and methods of use thereofDECIPHERA PHARMACEUTICALS LLC·Filed 2023·Granted Aug 5, 2025·0 cites·14 claims
- 0773US12071432B2Phenylaminopyrimidine amide autophagy inhibitors and methods of use thereofDECIPHERA PHARMACEUTICALS LLC·Filed 2022·Granted Aug 27, 2024·0 cites·28 claims
- 0870US12319655B2RAF kinase inhibitors and methods of use thereofDECIPHERA PHARMACEUTICALS LLC·Filed 2022·Granted Jun 3, 2025·0 cites·31 claims
- 0969US12479833B2Heteroarylaminopyrimidine amide autophagy inhibitors and methods of use thereofDECIPHERA PHARMACEUTICALS LLC·Filed 2022·Granted Nov 25, 2025·0 cites·30 claims
- 1066US2024376058A1Gcn2 and perk kinase inhibitors and methods of use thereofDECIPHERA PHARMACEUTICALS LLC·Filed 2024·Application pending·0 cites
- 1161US2025206729A1Dual raf and tubulin inhibitors and methods of use thereofDECIPHERA PHARMACEUTICALS LLC·Filed 2024·Application pending·0 cites
- 1261US2023357179A1Raf kinase inhibitors and methods of use thereofDECIPHERA PHARMACEUTICALS LLC·Filed 2022·Application pending·0 cites
- 1361US2025236609A1Vps34 inhibitors and methods of use thereofDECIPHERA PHARMACEUTICALS LLC·Filed 2024·Application pending·0 cites
- 1460US2024150368A1Ulk inhibitors and methods of use thereofDECIPHERA PHARMACEUTICALS LLC·Filed 2023·Application pending·0 cites
- 1558US11912668B2GCN2 and perk kinase inhibitors and methods of use thereofDECIPHERA PHARMACEUTICALS LLC·Filed 2021·Granted Feb 27, 2024·0 cites·15 claims
- 1656US2024116877A1Kit kinase inhibitors and methods of use thereofDECIPHERA PHARMACEUTICALS LLC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yu Mi Ahn files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →